Robot-assisted Laparoscopic Adenomyomectomy

Abstract

Abstract Adenomyosis is a benign uterine disorder where endometrial gland and stromal tissue are abnormally located within the myometrium. The common symptoms of adenomyosis are abnormal uterine bleeding (menorrhagia), dysmenorrhea, dyspareunia and infertility. The gold-standard method for treating adenomyosis is hysterectomy. For patients who desire to preserve their uterus, an alternative therapy would be adenomyomectomy which is sparing uterus. Such a procedure may be performed with open surgery or minimally invasive surgery. It is obvious that minimal invasive surgery would be better for the patient’s health. However, there is inadequate evidence to decidedly say which invasive surgery which invasive surgery would be best for the patient. We suggest that one of the newest techniques, robotic surgery is to be preferred an alternative approach for gynecological operations as well as would be an option for uterine surgery. This technique would allow for 3-D visualization and multijoint endowrist movement, which compared to laparoscopy, yields various advantages for surgeons. We therefore recruit seven participants diagnosed with symptomatic adenomyosis who admitted to Endometriosis and Chronic Pelvic Pain Center of Acibadem Altunizade Hospital between March 2019and January 2021 requested to preserve fertility. They all underwent robotic adenomyomectomy. The parameters evaluated herein will be, whether the pain and bleeding scores changed during the postoperative period, amount of blood loss during the operation and the associated decrease in Hg levels. Robotic adenomyomectomy is one of the uterus-sparing adenomyosis surgery methods and is safely applied in selected patients.